The US FDA has issued an Establishment Inspection Report for Piramal Pharma Limited s manufacturing facility located at Sellersville, USA and the inspection has now been successfully closed by the US FDA.
The US FDA has issued an Establishment Inspection Report for the Piramal Pharma Ltd s Lexington, Kentucky, USA manufacturing facility and the inspection has now been successfully closed by the US FDA.
The Board of Directors of Piramal Pharma Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.